Abstract:Objectives Lupus nephritis (LN) is a common and severe manifestation of SLE. Memory T (TM) cells have been implicated in the pathogenesis of SLE. This study aimed to investigate the clinical significance of T-cell subsets in a cohort of patients with LN. Method The peripheral blood T cells of 24 patients with LN and 13 patients with idiopathic membranous nephropathy (iMN) were analysed by flow cytometry. SLE disease activity was evaluated by SLE Disease Activity Index-2000 (SLEDAI-2K). Patients with LN were followed up for >6 months. Results Patients with LN presented lower frequency of CDC` cells and higher percentage of CD8(+) cells than patients with iMN, which was primarily due to lower CD4(+ )cell count. Interestingly, patients with LN under immunosuppressants had lower CD8(+)CD45R0 - TM frequency (p=0.007), fewer regulatory CD4(+) T cells (p=0.04) than those without immunosuppressants. Most CD4+ and CD8(+) TM cells in patients with LN showed an effector memory (C045RO(+)CCR7(+)) phenotype. The frequency of CD8(+)CD45R0(+) TM cells among the CD8(+) T cells was negatively correlated with white blood cell count, haemoglobin, platelet and serum levels of complements C3 and C4, but was positively correlated with serum IgG, erythrocyte sedimentation rate and SLEDAI score (p<0.05 each). Consistently, the frequency of CD8(+)CD45R0(+) TM cells was higher in patients with LN with positive antidouble-stranded DNA antibody, active renal disease, extrarenal manifestations and with sderotic glomeruli or moderate-to-severe mesangial hypercellularity in renal pathology (p<0.05). Additionally, CD8(+)CD45R0(+) TM cell frequency was significantly lower in patients with LN with renal complete remission than that in non-remission LN (18.7% vs 31.2%, p<0.05). None of these significant correlations was observed in CD4(+). TM cells. Conclusion The frequency of CD8(+) TM cells correlates with disease activity and treatment response to immunosuppressant in patients with LN. CD8(+) TM monitoring in patients with LN could provide more helpful indices for the monitoring and management of this disease.

Occurrence and role of Tph cells in various renal diseases

Pd-1(+)Cxcr5(-)Cd4(+)T Cells Are Correlated With The Severity Of Systemic Lupus Erythematosus

T peripheral helper (Tph) cells, a marker of immune activation in cancer and autoimmune disorders

Tph Cells Expanded in Primary Sjögren’s Syndrome

T peripheral helper cells in autoimmune diseases: What do we know?

Cytotoxic Tph subset with low B-cell helper functions and its involvement in systemic lupus erythematosus

Changes in Follicular Helper T Cells in Idiopathic Thrombocytopenic Purpura Patients.

Interferon lambda modulates proinflammatory cytokines production in PBMCs from patients with chronic kidney disease

Peripheral helper T cells in the pathogenesis of multiple sclerosis

Increased Circulating PD-1hiCXCR5- Peripheral Helper T Cells Are Associated with Disease Severity of Active Ulcerative Colitis Patients

T Follicular Helper Cells in Tertiary Lymphoid Structure Contribute to Renal Fibrosis by IL-21

T Follicular Helper Cells, T Follicular Regulatory Cells And Autoimmunity

T Follicular Helper Cells, T Follicular Regulatory Cells and Autoimmunity.

Trafficking between clonally related peripheral T-helper cells and tissue-resident T-helper cells in chronic GVHD

Expansion of T follicular helper cells is associated with disease progression in rat experimental membranous nephropathy model

Innate lymphoid cells in kidney diseases

Increased peripheral helper T cells type 17 subset correlates with the severity of psoriasis vulgaris

An Emerging Role of TIM3 Expression on T Cells in Chronic Kidney Inflammation

T Follicular Helper Cells Mediate Expansion of Regulatory B Cells Via IL-21 in Lupus-prone MRL/lpr Mice.

Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients

Aberrant expansion of follicular helper T cell subsets in patients with systemic lupus erythematosus